Cargando…
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
AIMS: No therapy has shown to reduce the risk of hospitalization for heart failure across the entire range of ejection fractions seen in clinical practice. We assessed the influence of ejection fraction on the effect of the sodium–glucose cotransporter 2 inhibitor empagliflozin on heart failure outc...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825259/ https://www.ncbi.nlm.nih.gov/pubmed/34878502 http://dx.doi.org/10.1093/eurheartj/ehab798 |